Regular ArticleSpecies-specific Prevalence of Vaginal Candidiasis Among Patients with Diabetes Mellitus and its Relation to their Glycaemic Status☆
References (30)
- et al.
Vulvovaginal candidiasis: clinical manifestations, risk factors, management algorithm
Obstet Gynecol
(1998) - et al.
Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations
Am J Obstet Gynecol
(1998) - et al.
Torulopsis glabrata vaginitis
Obstet Gynecol
(1995) - et al.
Insulin antibody responseto bovine insulin therapy: functional significance among insulin requiring young diabetics in India
Diabetes Res Clin Pract
(2000) - et al.
Changing pattern of candida species in a bone marrow transplant patient
J Infect
(1996) - et al.
Clinical and laboratory study of monilial vaginitis
Am J Obstet Gynecol
(1970) Diabetes presenting with phimosis
Lancet
(1971)Candidal vulvovaginitis
Clin Obstet Gynecol
(1993)Risk factor for candida vulvovaginitis
Obstet Gynecol Surv
(1992)- et al.
Candida tropicalis vulvovaginitis
Obstet Gynecol
(1985)
Resistance of yeast to azole-derivative antifungals
J Antimicrob Chemother
(1993)
Torulopsis glabrata vaginitis: clinical aspects and susceptibility to antifungal agents
Obstet Gynecol
(1990)
Treatment of vulvovaginal candidiasis in patients with diabetes
Diabetes Care
(1998)
Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation
Diabet Med
(1998)
Cited by (109)
Sickeningly Sweet: Infectious Complications of Diabetes
2023, Clinical Microbiology NewsletterType 2 Diabetes Mellitus
2022, Comprehensive PharmacologyComparison of SGLT1, SGLT2, and Dual Inhibitor Biological Activity in Treating Type 2 Diabetes Mellitus
2023, Advanced TherapeuticsCandida Isolation and Identification from Pregnant Women in Kirkuk City
2023, Medical Journal of BabylonDiabetes and Infection
2023, The Diabetes Textbook: Clinical Principles, Patient Management and Public Health Issues, Second Edition
- ☆
Please address all correspondence to: U. Banerjee, Additional Professor, Chief Laboratories for Clinical Mycology & Investigations of Infections in Immunocompromised Patients, Department of Microbiology, All India Institute of Medical Sciences, New Delhi 110029, India. Fax: 91-11-6862663. E-mail:[email protected]
Copyright © 2000 The British Infection Society. Published by Elsevier Ltd. All rights reserved.